Live from the NIH registry
Studies recruiting near Denton right now
Top 25 of 383 recruiting studies, sorted by proximity — each links to its official registry page
The Ailliance Post-Market Clinical Study
Spinal Deformity, Spinal Degenerative Disorder
N/A
Interventional 1,000 participants sought
American Neurospine Institute, PLLC — Frisco, Texas (19.0 mi)
· Sponsor: Medtronic Spinal and Biologics
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum Disorder, NMOSD
N/A
Observational 200 participants sought
Clinical Trial Site — Plano, Texas (29.0 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Left Atrial Appendage Closure
N/A
Interventional 444 participants sought
Baylor Scott and White Heart Hospital — Plano, Texas (29.0 mi)
· Sponsor: Baylor Research Institute
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 2
Interventional 200 participants sought
Arthritis and Rheumatology Ins — Allen, Texas (28.4 mi)
· Sponsor: Novartis Pharmaceuticals
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Baylor Scott and White - The Heart Hospital Baylor Plano — Plano, Texas (29.0 mi)
· Sponsor: Shockwave Medical, Inc.
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Texas Oncology - Northeast Texas ( Site 8002) — Flower Mound, Texas (14.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology-Northeast Texas — Denton, Texas (0.5 mi)
· Sponsor: Pfizer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
GI Alliance Southlake — Southlake, Texas (19.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (14.3 mi)
· Sponsor: Biogen
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Arthritis & Rheumatology Research Institute, PLLC — Frisco, Texas (19.0 mi)
· Sponsor: Pfizer
Acceptability and Efficacy of GO MOVE
Cerebral Palsy, Hemiplegic Cerebral Palsy
N/A
Interventional 50 participants sought
Scottish Rite for Children — Frisco, Texas (19.0 mi)
· Sponsor: Texas Scottish Rite Hospital for Children
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - McKinney — Prosper, Texas (19.7 mi)
· Sponsor: Ardelyx
The PREDICT Registry:
DCIS, Stage 0 Breast Cancer
N/A
Observational 3,000 participants sought
Texas Oncology — Plano, Texas (29.0 mi)
· Sponsor: PreludeDx
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Plano, Texas (29.0 mi)
· Sponsor: Vanda Pharmaceuticals
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Prosper, Texas (19.7 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Aim Trials, LLC — Plano, Texas (29.0 mi)
· Sponsor: TriGemX Bio, Inc.
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
Chronic Pruritus of Unknown Origin
Phase 3
Interventional 180 participants sought
Dermatology Solutions — Grapevine, Texas (19.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Duchenne Muscular Dystrophy
Phase 1
Interventional 83 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (14.3 mi)
· Sponsor: Sarepta Therapeutics, Inc.
OssDsign® Spine Registry Study ("Propel")
Degenerative Disc Disease, Spinal Stenosis
N/A
Observational 450 participants sought
Texas Spine Consultants — Addison, Texas (25.3 mi)
· Sponsor: OssDsign
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Gastric Adenocarcinoma, Gastric Cancer
Phase 2
Interventional 146 participants sought
Texas Oncology Grapevine — Grapevine, Texas (19.9 mi)
· Sponsor: Toray Industries, Inc
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Baylor Scott & White The Heart Hospital - Plano — Plano, Texas (29.0 mi)
· Sponsor: Penumbra Inc.
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Texas Oncology - Bedford — Bedford, Texas (25.8 mi)
· Sponsor: Daiichi Sankyo
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Asthma
N/A
Observational 2,500 participants sought
Lumi Research - Hurst - Site Number: 840164 — Hurst, Texas (27.3 mi)
· Sponsor: Sanofi
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Epic Clinical Research, LLC — Lewisville, Texas (14.6 mi)
· Sponsor: Altesa Biosciences, Inc.
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
The Heart Hospital Baylor Plano — Plano, Texas (29.0 mi)
· Sponsor: Shockwave Medical, Inc.